Clinical analysis of malignant gastrointestinal obstruction in terminal cancer patients.
- Author:
Do Ho MOON
1
;
Soung Min JEON
;
Na Ri LEE
;
Kil Hyo PARK
;
Byung Hyo CHA
;
Chai Young LEE
Author Information
1. Department of Internal Medicine, Sam Anyang Hospital, Anyang, Korea. mdmoon4@hanmail.net
- Publication Type:Original Article
- Keywords:
Gastrointestinal obstruction;
Palliative procedures;
Prognosis;
Terminal cancer patients
- MeSH:
Barium;
Colonoscopy;
Drug Therapy;
Endoscopy;
Female;
Gyeonggi-do;
Humans;
Male;
Malnutrition;
Medical Records;
Mortality;
Pancreas;
Prognosis;
Quality of Life;
Retrospective Studies;
Stomach
- From:Korean Journal of Medicine
2006;70(2):157-164
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Untreated malignant gastrointestinal obstruction is rapidly fatal and causes various symptoms and malnutrition, and so decreases the quality of life and shortens the survival. We reviewed clinical characteristics and analyzed prognostic factors in terminal cancer patients with malignant gastrointestinal obstruction. METHODS: We retrospectively reviewed the medical records of 63 patients with malignant gastrointestinal obstruction who had been confirmed by endoscopy or colonoscopy, upper gastrointestinal series or barium study and proper radiologic study at Sam Anyang hospital from May in 2002 to December in 2004. We excluded patients with palliative tumor resection. We analyzed prognostic factors for overall survival and symptom-free survival. RESULTS: There were 30 males (48%) and 33 females (52%), and median age of 63 patients was 64 years. The cause of malignant gastrointestinal obstruction was colorectal (26 patients, 41%), stomach (19, 30%), pancreas (4, 6%) and others (14, 23%). Twenty one patients (33%) had Eastern Cooperative Oncology Group (ECOG) performance status of 2 score and 42 patients (67%) 3 or 4 score. Forty two patients (67%) have been performed palliative procedures and 21 patients (33%) have not. Median survival of patients with palliative procedure was significantly higher than that of patients who have not been performed palliative procedures (144 days v 45 days, p=0.0001). By mutivariate analysis, palliative procedures and performance status were independent prognostic factors. However, age, gender, primary cancer, site of obstruction, and previous chemotherapy were not independent prognostic factors. Performance status was only independent prognostic factor that improves symptom free survival in patients with palliative procedures (p=0.014) and median symptom free survival was 90 days. There was no mortality on palliative procedures. CONCLUSIONS: We confirmed that palliative procedures and performance status are significant independent prognostic factors in terminal cancer patients with malignant gastrointestinal obstruction.
